Name: Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides，Ministry of Health (Peking University Third Hospital)
Basic and translational research in coronary heart disease and its complications
Early prevention: to find the susceptibility gene and new risk factors of the coronary heart disease and complications
Early prediction: to determine the new early stage biomarkers of the coronary heart disease and complications
Early treatment: to develop novel therapies targeting the coronary heart disease and complications
Early rehabilitation: to determine the protective effects and mechanisms of the rehabilitation training program on the coronary heart disease patients.
Contact: Zhizhen Lu
Tel: 010-82265885 010-82802306
Address: Institute of vascular medicine, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing，100191，P. R. China.